Evidence map›Paper›PMID 35654853›Full record

ArticleScientific reports2022

Trends and effect of marginalization on diabetes mellitus-related mortality in Mexico from 1990 to 2019.

Eduardo Gutiérrez-León, Ricardo Antonio Escamilla-Santiago, Pablo Martínez-Amezcua, Usama Bilal, Mariana Lazo, Rafael Ogaz-González, Malaquías López-Cervantes

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Mortality from type 2 diabetes mellitus across municipalities in Mexico.Archives of public health = Archives belges de sante publique · 2024
    Article
  5. [Cognitive function groups in older people and risk factors].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Article
  6. Article
  7. Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Eduardo Gutiérrez-LeónDepartment of Public Health, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Ricardo Antonio Escamilla-SantiagoDepartment of Public Health, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Pablo Martínez-AmezcuaDivision of General Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Usama BilalUrban Health Collaborative, Drexel Dornsife School of Public Health, Philadelphia, PA, USA.
Mariana LazoUrban Health Collaborative, Drexel Dornsife School of Public Health, Philadelphia, PA, USA.
Rafael Ogaz-GonzálezDepartment of Public Health, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Malaquías López-CervantesDepartment of Public Health, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico. mlopezcervantes@unam.mx.
Universidad Nacional Autónoma de México · MXColumbia University Irving Medical Center · USPhiladelphia Department of Public Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus (DM) is currently one of the leading causes of mortality worldwide. However, the disease evolves differently across countries. This study intends to characterize the trends and assess the potential effects of marginalization on DM mortality between 1990 and 2019 in Mexico. We analyzed death certificates that listed DM as the underlying cause of death (N = 1,907,173), as well as the extent to which DM mortality changes were associated with marginalization through an age-period-cohort analysis. DM mortality increased in Mexico between 1990 and 2019; the change was faster in the first half and slowed down after 2004. The highest marginalization quintiles drove the changes in DM mortality trends during the study period, with a higher risk of dying in these quintiles as age increased. In recent cohorts, the highest marginalization quintiles doubled the risk of dying from DM as compared to the lowest. Renal complications was the main death driver among persons with DM, with a marked increase between 1999 and 2001. In conclusion, Mexico continues to have a substantially high DM mortality, but its pace slowed over time. Moreover, subnational differences in marginalization can partially explain such a trend.

Indexed as

Diabetes MellitusCohort StudiesHumansKidneyMexico

Identifiers

PMID35654853
PMCPMC9163326
OpenAlexW4281802232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.